The primary objective is to evaluate the efficacy of rosuvastatin therapy on plasma lipid profile (Low Density Lipoprotein (LDL), High-Density Lipoprotein (HDL), total cholesterol, triglyceride) in patients with metabolic syndrome.
Age range
18 Years – 69 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Basal HDL-cholesterol Level
Timeframe: Baseline
HDL-cholesterol Level After 3 Months of Rosuvastatin Treatment
Timeframe: 3 months (from enrollment to last visit)
Basal LDL-cholesterol Level
Timeframe: Baseline
LDL-cholesterol Level After 3 Months of Rosuvastatin Treatment
Timeframe: 3 months (from enrollment to last visit)
Basal Total Cholesterol Level
Timeframe: Total cholesterol levels before (mean of visit 1 - screening and Visit 2 - enrollment)
Total Cholesterol Level After 3 Months of Rosuvastatin Treatment
Timeframe: 3 months (from enrollment to last visit)
Basal Triglyceride Level
Timeframe: Baseline
Triglyceride Level After 3 Months of Rosuvastatin Treatment
Timeframe: 3 months (from enrollment to last visit)
Number of Patients Who Reached Target Level of LDL-cholesterol After 3 Months of Rosuvastatin Treatment
Timeframe: 3 months (from enrollment to last visit)
Number of Patients Who Reached Target Level of HDL-cholesterol After 3 Months of Rosuvastatin Treatment
Timeframe: 3 months (from enrollment to last visit)
Number of Patients Who Reached Target Level of Non-HDL-cholesterol After 3 Months of Rosuvastatin Treatment
Timeframe: 3 months (from enrollment to last visit)